 | April 27-29, Fairmont Chicago | Registration now open!
|
|
The Journal of Clinical Investigation
Appointment of JCI Editor, 2012-2017
The ASCI is pleased to announce that Howard A. Rockman, M.D., will become the next Editor of the Journal of Clinical Investigation.
Dr. Rockman's five-year term starts March 2012, and his Editorial Board will draw multidisciplinary expertise from the Duke University School of Medicine and the University of North Carolina at Chapel Hill. He'll assume leadership of the JCI from Dr. Laurence Turka, whose term as Editor expires at the end of February 2012.
Dr. Rockman is Professor of Medicine, Professor in Cell Biology, and Professor in Molecular Genetics and Microbiology at the Duke University School of Medicine. He trained at McGill University, completed residencies in internal medicine at Montreal General Hospital and in cardiology at the University of California, San Diego, Medical Center, and did his fellowship in cardiology research at UCSD. He was elected to the ASCI in 1999.
About the JCI
The Journal of Clinical Investigation, with a 2010 Impact Factor of 14.152, is a premier venue for critical advances in biomedical research, authoritative reviews, and commentaries that place research articles in context. The findings published in the JCI have durable significance. According to a 1998 study of long-term impact, the long-term impact of the JCI is comparable to that of Nature and Science.
The JCI currently publishes about 300 research articles annually. Authors who submit their work to the JCI can expect quick and fair review. Accepted manuscripts are published within six to eight weeks of acceptance, one of the fastest times to publication among top-tier journals.
As of March 2007, JCI's Editorial Board is located at the University of Pennsylvania. Dr. Laurence A. Turka is the journal's Editor; Ushma S. Neill is Executive Editor.